• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[补体系统与糖尿病视网膜病变]

[Complement system and diabetic retinopathy].

作者信息

Zheng Bing-qing, Zheng Zhi

机构信息

Department of Ophthalmology, First People's Hospital of Shanghai, Shanghai Jiaotong University, Shanghai 200080, China.

出版信息

Zhonghua Yan Ke Za Zhi. 2013 Jul;49(7):661-4.

PMID:24257364
Abstract

The biological activities of complement system, which are activated mainly through classical pathway, alternative pathway and mannose-binding lectin pathway, include cytotoxicity, bacteriolysis, sterilization, cell regulation, immune adherence, neutralization and dissolution of virus and inflammatory mediators. It is well known that diabetic retinopathy (DR) is one of the common complications of diabetes mellitus and is the leading cause of blindness among working-age adults in the developed countries and regions, but the mechanism underlying its pathogenesis is not yet fully understood. Until now, numbers of studies showed that the activation of complement system is involved in the pathogenesis of DR. Naturally, these finding paves a way for the prevention and treatment of DR in the future.

摘要

补体系统的生物活性主要通过经典途径、替代途径和甘露糖结合凝集素途径激活,包括细胞毒性、细菌溶解、杀菌、细胞调节、免疫黏附、病毒中和与溶解以及炎症介质的作用。众所周知,糖尿病视网膜病变(DR)是糖尿病的常见并发症之一,是发达国家和地区劳动年龄成年人失明的主要原因,但其发病机制尚未完全明确。到目前为止,大量研究表明补体系统的激活参与了DR的发病过程。自然地,这些发现为未来DR的防治开辟了一条道路。

相似文献

1
[Complement system and diabetic retinopathy].[补体系统与糖尿病视网膜病变]
Zhonghua Yan Ke Za Zhi. 2013 Jul;49(7):661-4.
2
The role of mannose-binding lectin (MBL) in diabetic retinopathy: A scoping review.甘露糖结合凝集素(MBL)在糖尿病视网膜病变中的作用:一项范围综述。
Immunol Lett. 2024 Jun;267:106863. doi: 10.1016/j.imlet.2024.106863. Epub 2024 May 4.
3
The complement system and diabetic retinopathy.补体系统与糖尿病视网膜病变。
Surv Ophthalmol. 2024 Jul-Aug;69(4):575-584. doi: 10.1016/j.survophthal.2024.02.004. Epub 2024 Feb 23.
4
Complement involvement in neovascular ocular diseases.补体系统在新生血管性眼病中的作用。
Adv Exp Med Biol. 2012;946:161-83. doi: 10.1007/978-1-4614-0106-3_10.
5
Mannose-binding lectin (MBL) and vascular complications in diabetes.甘露糖结合凝集素(MBL)与糖尿病血管并发症
Horm Metab Res. 2005 Apr;37 Suppl 1:95-8. doi: 10.1055/s-2005-861372.
6
[Progress of research on pathogenesis and medical treatment of diabetic retinopathy].[糖尿病视网膜病变的发病机制与医学治疗研究进展]
Zhonghua Yan Ke Za Zhi. 2008 Jan;44(1):76-81.
7
[The complement system--structure, activation, regulation and function].[补体系统——结构、激活、调节与功能]
Tidsskr Nor Laegeforen. 1999 Jan 20;119(2):226-33.
8
Could diabetic retinopathy be an autoimmune disease?糖尿病视网膜病变会是一种自身免疫性疾病吗?
Med Hypotheses. 2007;68(5):1016-8. doi: 10.1016/j.mehy.2006.05.073. Epub 2006 Nov 27.
9
New perspectives on mannan-binding lectin-mediated complement activation.甘露聚糖结合凝集素介导补体激活的新视角。
Immunobiology. 2007;212(4-5):301-11. doi: 10.1016/j.imbio.2006.12.004. Epub 2007 Jan 22.
10
Analysis of the complement activation in mice.小鼠补体激活分析。
Methods Mol Biol. 2014;1100:365-71. doi: 10.1007/978-1-62703-724-2_31.